Medical Case Reports

A 60-year-old African American female with previously stable bipolar I disorder (BD1) presented after three weeks of depressed mood, anxiety, and decreased need for sleep.  P atient Health Questionnaire-9 (PHQ-9) - a  widely used tool for diagnosing depression was administered and her  score was 5. Her symptoms began within a week of receiving the second dose of the Pfizer-BioNTech COVID-19 vaccine. She  was assessed  a PHQ-9 score of 0  17 days before vaccination.  Her prescription of risperidone 2mg was temporarily increased to 3mg, and her symptoms returned to baseline after two weeks.   A 4 0-year-old white male  with previously stable BD1 and attention deficit hyperactivity disorder (ADHD) was voluntarily hospitalized due to a mixed episode with psychotic features.  His symptoms began after receiving the second dose of the Moderna COVID-19 vaccine and subsequently worsened after he discontinued his medications five days prior to ad...

55-year-old male with no previous mental illness background presented with full-blown manic symptoms following a severe course of COVID-19 infections that required admission. The patient presented with behavioral disturbance after a diagnosis of COVID-19. He exhibited symptoms including irritability, verbal and physical aggressiveness, increased goal-directed activity, elated and expansive mood, increased energy, grandiosity and inflated self-esteem, and decreased need for sleep. With the diagnosis of bipolar I disorder, current manic episode, severe, with psychotic feature, and first manic episode due to COVID-19 infection, he was admitted to the psychiatry emergency ward. By day 21, after treatment, he was discharged from the hospital with full improvement.  This case presents an Ethiopian Perspective . Similar cases were described for a 44-year old Polish man with no psychiatric history and another healthy  51-year old Chinese male .  A study of more than 11 million ...